Schedule 13G ownership disclosure
DexCom Inc
Common Stock · CUSIP: 252131107
Event date: 2025-09-30
- Filing-level shares
- 49,455,578
- Percent of class
- 12.61%
- The Vanguard Group
Shares: 49,455,578 · Class: 12.61%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000102
- Form type
- SCHEDULE 13G/A
- Filer
- DEXCOM INC
- CIK
- CIK 1093557
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership